• Darwin AG rebranded to Novogenia, aligning the listed parent with its core operating brand in human genetics.
• Name change registered in the commercial register; follows a June 26, 2026 shareholder vote.
• Business model, strategy, operations, listing, and shareholder rights unchanged; focus remains on growth driven by wholly owned Novogenia GmbH.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Darwin AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2365958_en) on July 15, 2026, and is solely responsible for the information contained therein.